{"date":"2026-03-10","count":90,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1734-2026-03-10-1952-92x690","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"19:52:05","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-03-10 19:52，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-03-10-1949-k4guhu","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"19:49:02","subject":"公告本公司內部稽核主管變動","clause":"第8款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-03-10 19:49，「公告本公司內部稽核主管變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-03-10-1948-17aa6cr","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"19:48:49","subject":"本公司董事會決議盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-03-10 19:48，「本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-03-10-1948-11b1948","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"19:48:29","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-03-10 19:48，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-03-10-1946-brax5m","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"19:46:07","subject":"本公司董事會決議通過114年度合併財務報告案","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-03-10 19:46，「本公司董事會決議通過114年度合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-10-1939-1pdmvbo","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:39:30","subject":"董事會決議召開一一五年股東常會","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-10 19:39，「董事會決議召開一一五年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-10-1939-92x690","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:39:19","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-10 19:39，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-10-1939-120ib8z","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:39:03","subject":"董事會決議通過一一四年度合併財務報告","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-10 19:39，「董事會決議通過一一四年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1925-1g6i233","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:25:01","subject":"公告本公司董事長異動","clause":"第6款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 19:25，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1923-1vjeb6y","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:23:57","subject":"公告本公司董事會補行委任薪酬委員會委員","clause":"第6款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 19:23，「公告本公司董事會補行委任薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1923-1jhewlf","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:23:16","subject":"公告本公司公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 19:23，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1922-1tosxb3","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:22:39","subject":"公告本公司112年度現金增資計畫變更事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 19:22，「公告本公司112年度現金增資計畫變更事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1919-11b1948","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:19:42","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 19:19，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-10-1905-1d29v9p","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"19:05:43","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-10 19:05，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-03-10-1900-gu3l9d","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"19:00:09","subject":"公告本公司董事會決議不發股利","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-03-10 19:00，「公告本公司董事會決議不發股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-03-10-1859-5xjbf0","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:59:41","subject":"公告本公司董事會決議召開115年股東會相關事宜","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-03-10 18:59，「公告本公司董事會決議召開115年股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1859-1ctgck9","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:59:02","subject":"本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 18:59，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-03-10-1858-5j9yh6","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:58:55","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-03-10 18:58，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-10-1854-1hds7fq","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:54:25","subject":"公告本公司董事會通過114年第四季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-10 18:54，「公告本公司董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2026-03-10-1844-1063vlj","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"18:44:21","subject":"公告本公司董事會決議召開2026年股東常會事宜","clause":"第32款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2026-03-10 18:44，「公告本公司董事會決議召開2026年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2026-03-10-1841-1m8c6w5","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"18:41:26","subject":"本公司2025年度合併財務報告業經董事會決議通過","clause":"第43款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2026-03-10 18:41，「本公司2025年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-10-1835-11qiaz3","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:35:20","subject":"本公司董事會決議召開115年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-10 18:35，「本公司董事會決議召開115年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-10-1832-13p19vs","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"18:32:34","subject":"(更正)公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-10 18:32，「(更正)公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-10-1830-3kb7gv","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"18:30:30","subject":"本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-10 18:30，「本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-10-1830-5xp9q1","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"18:30:17","subject":"公告本公司配合會計師事務所內部調整更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-10 18:30，「公告本公司配合會計師事務所內部調整更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-10-1830-5j9yh6","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"18:30:03","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-10 18:30，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-10-1829-11b1948","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"18:29:35","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-10 18:29，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-03-10-1814-1vpb5p2","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:14:05","subject":"本公司董事會決議通過本公司114年度合併財務報告","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-03-10 18:14，「本公司董事會決議通過本公司114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-03-10-1812-kr1eht","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:12:40","subject":"公告本公司董事會決議通過投資有價證券","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-03-10 18:12，「公告本公司董事會決議通過投資有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-03-10-1810-1fni8xi","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:10:23","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞案","clause":"第53款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-03-10 18:10，「公告本公司董事會通過114年度員工酬勞及董事酬勞案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-03-10-1806-11wvmau","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:06:53","subject":"公告本公司董事會決議召開115年度股東常會事宜","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-03-10 18:06，「公告本公司董事會決議召開115年度股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-03-10-1806-1m38kv8","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:06:09","subject":"公告本公司114年度合併財務報告業經董事會通過","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-03-10 18:06，「公告本公司114年度合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-03-10-1805-17snutz","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:05:50","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-03-10 18:05，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-03-10-1805-87ja50","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:05:37","subject":"董事會決議114年度股利分派","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-03-10 18:05，「董事會決議114年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-03-10-1805-1mvy42n","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"18:05:28","subject":"公告本公司董事會決議股利分派情形","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-03-10 18:05，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-03-10-1754-181p2zr","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:54:56","subject":"公告本公司114年股東常會通過之私募普通股案於期限屆滿後不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-03-10 17:54，「公告本公司114年股東常會通過之私募普通股案於期限屆滿後不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-03-10-1753-92x690","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:53:58","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-03-10 17:53，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-03-10-1749-1rr2xbh","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:49:41","subject":"公告本公司民國114年度合併財務報告業經提報董事會","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-03-10 17:49，「公告本公司民國114年度合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-03-10-1746-1dv0xgh","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:46:08","subject":"公告本公司董事會決議之股利分派","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-03-10 17:46，「公告本公司董事會決議之股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-10-1744-9592h5","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:44:49","subject":"本公司擬參與長聯科技股份有限公司預計辦理之現金增資案(補充115/2/2公告:增加投資金額)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-10 17:44，「本公司擬參與長聯科技股份有限公司預計辦理之現金增資案(補充115/2/2公告:增加投資金額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-03-10-1743-13bqai2","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:43:43","subject":"本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-03-10 17:43，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-03-10-1741-1vwhr84","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:41:57","subject":"本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-03-10 17:41，「本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-03-10-1738-1o3mse2","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:38:54","subject":"公告本公司董事會通過民國114年度個體財務報表及合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-03-10 17:38，「公告本公司董事會通過民國114年度個體財務報表及合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-03-10-1738-hurcou","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:38:42","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-03-10 17:38，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-03-10-1738-473a29","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:38:36","subject":"115/3/10董事會通過 115年度股東常會召集事由案","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-03-10 17:38，「115/3/10董事會通過 115年度股東常會召集事由案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-03-10-1732-13bqai2","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:32:47","subject":"本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-03-10 17:32，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-10-1728-nt5gla","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:28:29","subject":"公告董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-10 17:28，「公告董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-03-10-1728-1xu0c7w","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:28:22","subject":"公告本公司董事會決議115年股東常會召開事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-03-10 17:28，「公告本公司董事會決議115年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-03-10-1719-1qt7osx","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:19:08","subject":"公告本公司115/3/10董事會通過114年度合併財務報告案","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-03-10 17:19，「公告本公司115/3/10董事會通過114年度合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-10-1715-jlx27i","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:15:50","subject":"代本公司之重要子公司威茂(股)公司公告董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-10 17:15，「代本公司之重要子公司威茂(股)公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-10-1715-1dikn9j","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:15:13","subject":"代子公司威茂股份有限公司公告董事會(代行股東會職權)重要決議事項","clause":"第18款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-10 17:15，「代子公司威茂股份有限公司公告董事會(代行股東會職權)重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-03-10-1714-1nb8hvk","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:14:44","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-03-10 17:14，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-10-1710-1tz0zze","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:10:46","subject":"(更正)公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-10 17:10，「(更正)公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-10-1707-2c1x0w","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:07:48","subject":"公告本公司董事會通過115年股東會召開相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-10 17:07，「公告本公司董事會通過115年股東會召開相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-10-1706-bwopfv","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:06:14","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-10 17:06，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-10-1704-13c3d3u","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"17:04:01","subject":"本公司董事會決議召開股東常會","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-10 17:04，「本公司董事會決議召開股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-10-1703-1ve1n33","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:03:35","subject":"公告本公司董事會決議通過廠房及辦公室新建工程之資本支出預算案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-10 17:03，「公告本公司董事會決議通過廠房及辦公室新建工程之資本支出預算案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-10-1703-5rax5d","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:03:05","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-10 17:03，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-10-1701-1xl66gd","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"17:01:29","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-10 17:01，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-03-10-1659-18uudi1","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"16:59:31","subject":"本公司董事會決議召開股東常會相關事宜","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-03-10 16:59，「本公司董事會決議召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-10-1659-1d29v9p","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:59:21","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-10 16:59，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-10-1656-9prqx6","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"16:56:30","subject":"本公司董事會決議通過股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-10 16:56，「本公司董事會決議通過股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-10-1656-14c2sun","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"16:56:02","subject":"本公司董事會決議辦理現金減資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-10 16:56，「本公司董事會決議辦理現金減資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-10-1655-124frod","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"16:55:39","subject":"本公司董事會決議通過民國114年度董事酬勞及員工酬勞分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-10 16:55，「本公司董事會決議通過民國114年度董事酬勞及員工酬勞分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-10-1655-hurcou","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"16:55:17","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-10 16:55，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-10-1654-1r1w2m4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"16:54:41","subject":"本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-10 16:54，「本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-10-1653-bwopfv","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:53:15","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-10 16:53，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-10-1653-1e1alpo","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"16:53:07","subject":"公告本公司終止與財團法人工業技術研究院之技術授權暨服務契約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-10 16:53，「公告本公司終止與財團法人工業技術研究院之技術授權暨服務契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-10-1653-b9gsdb","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:53:01","subject":"公告本公司員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-10 16:53，「公告本公司員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-10-1652-fqsc9p","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:52:49","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-10 16:52，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-10-1652-1lzzfh4","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:52:38","subject":"公告本公司董事會決議以私募方式辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-10 16:52，「公告本公司董事會決議以私募方式辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-10-1652-1id9w38","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:52:26","subject":"公告本公司董事會決議114年股東常會通過之私募剩餘額度於期屆滿時不再續行辦理案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-10 16:52，「公告本公司董事會決議114年股東常會通過之私募剩餘額度於期屆滿時不再續行辦理案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-10-1651-5j9yh6","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:51:54","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-10 16:51，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-03-10-1649-e6hr0k","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:49:44","subject":"公告本公司董事會通過114年度合併財務報表","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-03-10 16:49，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-10-1649-6h4lg0","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"16:49:19","subject":"公告本公司董事會決議召開115年股東常會及相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-10 16:49，「公告本公司董事會決議召開115年股東常會及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-03-10-1640-17q2ldr","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:40:57","subject":"本公司董事會通過召集115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-03-10 16:40，「本公司董事會通過召集115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-10-1638-zwkvtc","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:38:26","subject":"公告更正本公司私募專區資訊(董事會決議日起兩日內應申報相關資訊)","clause":"第53款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-10 16:38，「公告更正本公司私募專區資訊(董事會決議日起兩日內應申報相關資訊)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-03-10-1630-12vc7am","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:30:44","subject":"公告本公司董事會決議召開115年股東常會(召開方式：實體股東會)","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-03-10 16:30，「公告本公司董事會決議召開115年股東常會(召開方式：實體股東會)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-03-10-1622-bwopfv","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:22:16","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-03-10 16:22，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-03-10-1618-1jp3ewj","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:18:47","subject":"公告本公司董事會通過114年度財務報表","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-03-10 16:18，「公告本公司董事會通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-10-1602-1u7pahz","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"16:02:37","subject":"董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-10 16:02，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-03-10-1600-9x850j","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"16:00:24","subject":"公告本公司自然人董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-03-10 16:00，「公告本公司自然人董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-10-1550-5j9yh6","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"15:50:25","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-10 15:50，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-10-1547-1fqkmsr","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-10","time":"15:47:00","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-10 15:47，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-10-1515-pdgdtn","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"15:15:22","subject":"本公司有價證券近期達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-10 15:15，「本公司有價證券近期達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-10-1506-1e7ugzx","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"15:06:21","subject":"公告本公司114年度合併財務報告經董事會通過","clause":"第31款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-10 15:06，「公告本公司114年度合併財務報告經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-10-1502-54swv6","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"15:02:05","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-10 15:02，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-10-1437-ca7jki","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"14:37:23","subject":"公告本公司訂定114年下半年度現金股利除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-10 14:37，「公告本公司訂定114年下半年度現金股利除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-10-1430-1d29v9p","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-10","time":"14:30:23","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-10 14:30，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-03-10-0924-1d29v9p","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-03-10","time":"09:24:16","subject":"公告本公司變更股務代理機構事宜","clause":"第51款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-03-10 09:24，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}